RE:RE:RE:RE:RE:RE:RE:RE:RE:OHHHH DEAR.... TD JUST CUT TO HOLD FROM BUYThis is from their March 2016 Annual Information Form:
Concordia North America, operating through its Barbados office, sells substantially all of its pharmaceutical products
directly to three major wholesalers in the United States, who combined account for approximately 95% of Concordia
North America’s total sales through wholesalers and approximately 80% of the operating segment’s total revenue. Also:
Warehousing, distribution, logistics, customer service and accounts receivable were transitioned from Shionogi’s
Transition Services to Cardinal Specialty Pharmaceutical Services in January 2014. Management of Concordia North
America believes that such outsourcing relationships with leading providers of pharmaceutical contract services are an
efficient means of pursuing its business plans and intends to pursue this strategy in the future. Now of course you say that's irrelevant. Well dig further.
Cardinal Specialty Pharmaceutical Services is the division of Cardinal Health, a major US wholesalers, that serves Concordia as noted above. Cardinal Health is in turn in an exclusive partnership with CVS Caremark, a divison of CVS Health, in an operation called ''Red Oak Sourcing'', the largest sourcer of pharma generics in the US. As you know, they distribute CXR's Nilandron ( see Cardinal Health Specialty Pharma ).
I don't know where you get your confidence in this management buddy, but for your money's sake, hedge some.
Beckysboss wrote: Fudster, maybe CVS dropped it because it didn't sell thru their chain... immaterial to both Concordia and CVS... duhhhhh.....you can twist, turn and spin it , the retail shorts are setting up to get burned.
CVS Health confirmed this week that Nilandron®, Concordia's treatment for metastatic prostate cancer, and Dutoprol®, a treatment for high blood pressure, will be removed from CVS Health's formulary.
Concordia believes this exclusion is immaterial to its business. According to IMS prescription data, CVS did not reimburse for Nilandron® at all in the past three years and has reimbursed Dutoprol® twice in 2016.